Emma Thomas, DPhil, is an Analyst at CBPartners
Connect with Emma Thomas, DPhil
A recent study of the review of new medicines by regulatory and HTA bodies has revealed areas of misalignment in their processes, highlighting unique challenges in the pathway to patient access.
Sign up here to receive our monthly newsletter, featuring our latest blog posts, news, and updates.
Copyright © CBPartners. All Rights Reserved.
Site Design & Build by Thinking Juice